Frank D'Amelio, Executive Vice President, Business Operations and Chief Financial Officer of Pfizer Inc., arrives at Portcullis House to attend a parliamentary business and enterprise committee hearing on the future of AstraZeneca, in central London, May 13, 2014. REUTERS/Andrew Winningsaid on Wednesday Chief Financial Officer Frank D'Amelio, 63, would retire after nearly 15 years at the company.
The drugmaker has started an external search for the successor of D'Amelio, who also served as executive vice president of global supply. During his tenure, Pfizer slimmed down its business through sales to focus on its newer, patent-protected portfolio of profitable drugs such as cancer treatment Ibrance.
D'Amelio played crucial roles in the company's 2011 sale of its capsule-making unit to private equity firm KKR & Co
Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Pfizer agrees to let other companies make its Covid pill to allow broader global accessDrugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental Covid-19 pill, a move that could make the treatment available to more than half of the world’s population.
Sumber: NBCNews - 🏆 10. / 86 Baca lebih lajut »
Pfizer agrees to let other companies make its COVID-19 pillDrugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population. In a statement issued Tuesday, Pfizer said it would grant a license for the antiviral pill to the Geneva-based Medicines Patent Pool, which would let generic drug companies produce the pill for use in 95 countries, making up about 53% of the world’s population. “It’s quite significant that we will be able to provide access to a drug that appears to be effective and has just been developed, to more than 4 billion people,” Esteban Burrone, head of policy at the Medicines Patent Pool, said.
Sumber: YahooNews - 🏆 380. / 59 Baca lebih lajut »
Pfizer agrees to let other companies make its COVID-19 pillLONDON (AP) — Drugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population. mikewsyx6 I ran across a documentary called 'Covid-19, Race for the Vaccine' about Pfizer's efforts to get the vaccine out. It's well worth watching. Glad they're willing to share this new pill to help people, not their bottom line. kxly4news This is all turning out to be very lucrative for pfizer. Good thing they got all that money and support from Operation Warp Speed huh? Thank you pfizer
Sumber: AP - 🏆 728. / 51 Baca lebih lajut »